Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also... see more

Recent & Breaking News (NYSE:GSK)

GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons

Business Wire June 21, 2023

GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to "Ask2BSure" about Meningitis B

Business Wire June 20, 2023

GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US

Business Wire June 1, 2023

BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition

Business Wire May 16, 2023

SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress

GlobeNewswire May 11, 2023

SCYNEXIS Announces First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 11, 2023

US FDA Approves GSK's AREXVY, the World's First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults

Business Wire May 3, 2023

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

Business Wire April 18, 2023

GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection

GlobeNewswire March 30, 2023

GSK and Earvin "Magic" Johnson Partner to Raise Awareness of Risk of RSV in Older Adults

Business Wire March 14, 2023

The Year of the Tripledemic

TheNewsWire January 3, 2023

Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets

GlobeNewswire December 13, 2022

New data at ASH underscore the potential for durable, clinically important responses with momelotinib for myelofibrosis patients

Business Wire December 11, 2022

Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr

GlobeNewswire November 8, 2022

GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr

GlobeNewswire September 22, 2022

SpringWorks Announces Expansion of Global, Non-Exclusive Collaboration with GSK for Nirogacestat in Combination with Blenrep in Patients with Multiple Myeloma

GlobeNewswire September 7, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

Newsfile September 1, 2022

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

Newsfile August 17, 2022

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

Accesswire August 16, 2022

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

Newsfile August 16, 2022